Management of White Coat Hypertension in Pregnancy

Diagnostic Confirmation

Home BP monitoring is mandatory in the management of white coat hypertension, as recommended by the American Heart Association 1

The European Society of Cardiology recommends that antihypertensive medications should be withheld from women with confirmed white coat hypertension, as lowering BP below 80 mmHg diastolic may impair uteroplacental perfusion and jeopardize fetal development 2
A meta-analysis shows a direct linear relationship between treatment-induced fall in mean arterial pressure and proportion of small-for-gestational-age infants, highlighting the importance of careful consideration of antihypertensive therapy 3

The European Society of Cardiology recommends laboratory surveillance, including assessment for proteinuria at least twice weekly in the second half of pregnancy using urine protein/creatinine ratio (abnormal if ≥30 mg/mmol) 4, 1
Monitoring of hemoglobin and platelet counts is essential, as decreasing values may indicate progression to preeclampsia, according to the American College of Obstetricians and Gynecologists 5, 1
Evaluation of liver enzymes, renal function, and uric acid levels is crucial, as elevated uric acid is associated with worse maternal and fetal outcomes, as recommended by the European Society of Cardiology 1, 5

The American Heart Association recommends evaluating patients for symptoms of preeclampsia, including severe headache, visual disturbances, and epigastric pain 1
Assessing for neurological signs, including clonus, is essential in patients with white coat hypertension, according to the American Academy of Neurology 1

The European Society of Cardiology recommends initiating antihypertensive therapy only when both office BP and home BP are elevated, with a target BP below 140/90 mmHg but maintaining diastolic BP above 80 mmHg 2, 3

The European Society of Cardiology recommends immediate hospitalization and treatment with IV labetalol, oral nifedipine, or IV hydralazine if BP reaches ≥160/110 mmHg with confirmed home BP elevation 4, 3

The American College of Cardiology recommends continued BP monitoring for 72 hours in hospital and 7-10 days postpartum, as well as annual cardiovascular risk assessment lifelong, for women with white coat hypertension during pregnancy 3